Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis
Fingerprint
Dive into the research topics of 'Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis'. Together they form a unique fingerprint.